Affiliation:
1. Saint-Petersburg State Pediatric Medical University
2. Children’s Infectious Diseases Hospital № 3
3. Anti-tuberculosis Dispensary № 12
4. City Anti-tuberculosis Dispensary
Abstract
Тhe aim: to analyze the cases of complications of BCGvaccination in children, potential risk factors, patient management tactics.Materials and methods: The statistical data on local complications of BCG-M vaccination in Saint Petersburg (Russia) from 2012 to 2019 was studied. To verify the diagnosis of post-vaccinal complication the Mantoux test, diaskintest or QuantiFERON-TB, X-ray examination, morphological and bacteriological examination were used in cases of indication. Observations of 22 children aged from 1,5 months to 1,5 years with complications after vaccination with BCG-M were analyzed.Results. Since 2010, the sparing BCG-M vaccine has been used in St. Petersburg for primary immunization. The incidence of local complications over the past 8 years was 0,002% – 0,012% of the number of vaccinated children. A cold abscess was diagnosed in 11 (50,0%), BCG-lymphadenitis in 9 (40,9%), an ulcer in 2 (9,1%) children. In 14 (63,6%) of 22 children complications of vaccination were detected in the phase of abscess formation. Fore children underwent surgery with diagnoses of nonspecific lymphadenitis (3), soft tissue abscess (1). In these cases, diagnoses of BCG-M complications was established only after morphological examination of the surgical material. In children with complications while the results of Mantoux test were positive, results of diaskintest and QuantiFERON-TB were negative. The detection of Mycobacterium bovis BCG was possible in 5 patients by culture and polymerase chain reaction methods. 2 clinical cases are given.Conclusion: It is necessary to increase the knowledge of pediatricians, pediatric surgeons, nurses of BCG vaccination techniques, diagnosis and treatment of post-vaccination complication, indications for dispensary observation.
Reference18 articles.
1. Shvarts YaSh, Stavitskaya NV, Kudlay DA. BCG vaccination as protection from COVID-19: epidemiological andmolecularbiological aspects. Tuberculez i bolezni legkih. 2020; 5 (98): 6-14.
2. Tkachuk AP, Karyagina AS, Logunov DYu, Ginzburg AL The prospects of creation of new vaccines for prevention of tuberculosis Medicinskij al’yans.2013; 3: 25-37.
3. Aksenova, VA. Levi DT., Aleksandrova NV., Kudlay DA. Сurrent tuberculosis incidence among children; medicines for prevention and diagnosis of TB // BIOpreparaty. Profilaktika, diagnostika, lechenie. 2017; 17(3):145-151.
4. Korol OI, Lozovskaya ME. Tuberculosis in children and teenagers. Saint-Petersburg (Russia) Piter; 2005. 432 p.
5. Lozovskaya MЕ, Nikiforenko NN, Klochkova LV, Vasilieva EB, Mosina AV. Clinical and epidemiological features of tuberculosis in young children in Saint Petersburg. Pediatr. 2018; 9(5):5-12.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Multiple drugs;Reactions Weekly;2021-12